Bydureon Add-On Therapy in T2D OK ' d by FDA

(MedPage Today) -- For patients not achieving glycemic control with basal insulin
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Endocrinology | Insulin